Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques
Molecular Therapy2015Vol. 23(6), pp. 1066–1076
Citations Over TimeTop 10% of 2015 papers
Laura Evgin, Sergio A. Acuña, Christiano Tanese de Souza, Monique Marguerie, Chantal G. Lemay, Carolina S. Ilkow, C. Scott Findlay, Theresa Falls, Kelley A. Parato, David Hanwell, Alyssa Goldstein, Roberto Lopez, Sandra Lafrance, Caroline J. Breitbach, David H. Kirn, Harold Atkins, Rebecca C. Auer, Joshua M. Thurman, Gregory L. Stahl, John D. Lambris, John C. Bell, J. Andrea McCart
Related Papers
- → The mechanisms of genetically modified vaccinia viruses for the treatment of cancer(2015)31 cited
- → Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators(2020)19 cited
- → Anti‐tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies(2014)8 cited
- Advances of Oncolytic Vaccinia Virus for the Treatment of Tumor(2012)
- → Oncolytic vaccinia virus: a promising agent for cancer treatment(2016)